HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

WGRX

Wellgistics Health Inc

Last Close
Apr 03 • 04:00PM ET
4.51
Dollar change
-0.05
Percentage change
-1.10 		%
Healthcare • Pharmaceutical Retailers • USA • NASD
Scroll to Statements
Index- P/E- EPS (ttm)-0.13 Insider Own85.20% Shs Outstand51.94M Perf Week16.54%
Market Cap234.25M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float7.69M Perf Month55.52%
Income-6.86M PEG- EPS next Q- Inst Own- Short Float0.20% Perf Quarter-
Sales18.13M P/S12.92 EPS this Y- Inst Trans- Short Ratio0.09 Perf Half Y-
Book/sh0.13 P/B34.79 EPS next Y- ROA-23.78% Short Interest0.02M Perf Year-
Cash/sh0.02 P/C227.43 EPS next 5Y- ROE-357.65% 52W Range2.32 - 5.69 Perf YTD18.37%
Dividend Est.- P/FCF- EPS past 5Y- ROI-35.55% 52W High-20.74% Beta-
Dividend TTM- Quick Ratio0.13 Sales past 5Y0.00% Gross Margin3.60% 52W Low94.40% ATR (14)0.68
Dividend Ex-Date- Current Ratio0.38 EPS Y/Y TTM-136.98% Oper. Margin-33.90% RSI (14)57.14 Volatility16.48% 19.93%
Employees- Debt/Eq3.73 Sales Y/Y TTM- Profit Margin-37.82% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq1.86 EPS Q/Q-302.90% Payout- Rel Volume0.19 Prev Close4.56
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume167.69K Price4.51
SMA2019.57% SMA5029.21% SMA20029.21% Trades Volume32,850 Change-1.10%
Mar-27-25 08:05AM
Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025
(GlobeNewswire)
Mar-18-25 07:40AM
Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models
(GlobeNewswire) +14.61%
Mar-04-25 05:18PM
Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure
(GlobeNewswire)
07:40AM
Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND
(GlobeNewswire)
Feb-26-25 07:40AM
Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market
(GlobeNewswire)
01:15PM Loading…
Feb-25-25 01:15PM
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering
(ACCESS Newswire) -9.90%
Feb-24-25 04:05PM
Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering
(GlobeNewswire) -20.47%
Feb-21-25 08:05AM
Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering
(GlobeNewswire)
Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.